Open-Label Study of Setmelanotide in Hypothalamic Obesity
Study sponsor: Rhythm Pharmaceuticals, Inc. · RYTM
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2022-06-28Actual
Enrollment · participants18Actual
Source updated2025-02-07Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.